[iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2018 BEIJING, DECEMBER 20, 2018 (GLOBE NEWSWIRE) iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), a major provider in Chinas fast growing private preventive healthcare services mar]
[iKang Announces Unaudited Financial Results for the Fiscal Second Quarter Ended September 30, 2018 BEIJING, DECEMBER 20, 2018 (GLOBE NEWSWIRE) iKang Healthcare Group, Inc. (iKang or the Company) (Nasdaq: KANG), a major provider in Chinas fast growing private preventive healthcare services mar]
[SCHEDULE 13D iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Boquan He Unit 3213, Metro Plaza No. 183-187 Tianhe Ro]
[SCHEDULE 13D iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Boquan He Unit 3213, Metro Plaza No. 183-187 Tianhe Ro]
[SCHEDULE 13D iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Boquan He Unit 3213, Metro Plaza No. 183-187 Tianhe Ro]
[SCHEDULE 13D iKang Healthcare Group, Inc. (Name of Issuer) Class A Common Shares, par value US$0.01 per share** American Depositary Shares, each representing 1/2 Class A Common Share (Title of Class of Securities) 45174L108*** (CUSIP Number) Mr. Boquan He Unit 3213, Metro Plaza No. 183-187 Tianhe Ro]
